These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. Abdalla I, Thisted RA, Heimann R. Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147 [Abstract] [Full Text] [Related]
5. Outcomes of women with metachronous breast and ovarian carcinomas. Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK. Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424 [Abstract] [Full Text] [Related]
6. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses. Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M. Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018 [Abstract] [Full Text] [Related]
8. Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients. Tilanus-Linthorst MM, Bartels KC, Alves C, Bakri B, Crepin E, van den Ouweland A, Klijn JG, Meijers-Heijboer H, Brekelmans CT. Breast Cancer Res Treat; 2006 Jan; 95(2):117-23. PubMed ID: 16319990 [Abstract] [Full Text] [Related]
11. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. Vichapat V, Garmo H, Holmqvist M, Liljegren G, Wärnberg F, Lambe M, Fornander T, Adolfsson J, Lüchtenborg M, Holmberg L. J Clin Oncol; 2012 Oct 01; 30(28):3478-85. PubMed ID: 22927521 [Abstract] [Full Text] [Related]
14. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE. Breast Cancer Res Treat; 2008 Jul 01; 110(1):189-97. PubMed ID: 17687645 [Abstract] [Full Text] [Related]
16. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer. Sandberg ME, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, Czene K. Breast Cancer Res Treat; 2012 Jul 01; 134(2):793-800. PubMed ID: 22622811 [Abstract] [Full Text] [Related]
17. Survival impact of integrative cancer care in advanced metastatic breast cancer. Block KI, Gyllenhaal C, Tripathy D, Freels S, Mead MN, Block PB, Steinmann WC, Newman RA, Shoham J. Breast J; 2009 Jul 01; 15(4):357-66. PubMed ID: 19470134 [Abstract] [Full Text] [Related]
18. Increased lymph node positivity in multifocal and multicentric breast cancer. Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T. J Am Coll Surg; 2009 Jan 01; 208(1):67-74. PubMed ID: 19228505 [Abstract] [Full Text] [Related]
19. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection. Schootman M, Fuortes L, Aft R. Breast Cancer Res Treat; 2006 Sep 01; 99(1):91-5. PubMed ID: 16555124 [Abstract] [Full Text] [Related]